Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Feb 7, 2008; 14(5): 685-692
Published online Feb 7, 2008. doi: 10.3748/wjg.14.685
Published online Feb 7, 2008. doi: 10.3748/wjg.14.685
Total inflow occlusion group (n = 28) | Hemihepatic occlusion group (n = 30) | P value | |
Resected liver weight (g) | 443.9 ± 10.7 (150-1670) | 422.7 ± 17.4 (180-1320) | 0.29 |
Overall ischemic time (min) | 96.0 ±10.9 (62-196) | 94.2 ±9.9 (64.5-188) | 0.28 |
Liver transection time (min) | 86.4 ± 5.3 (64-171) | 84.4 ± 5.2 (62-174.5) | 0.54 |
Area of liver cut surface (cm2) | 103.1 ± 8.7 (62-208) | 101.2 ± 6.9 (64-204) | 0.86 |
Overall operative blood loss (mL) | 6.82 ± 0.32 (3.8-11.5) | 6.65 ± 0.26 (3.9-10.8) | 0.37 |
Blood loss during parenchymal transection (mL) | 1685 ± 170 (500-4800) | 1159 ± 221 (400-4200) | 0.049 |
Blood loss in declamping period (mL) | 1015 ± 112 (400-4300) | 974 ± 101 (300-4200) | 0.51 |
Need for blood transfusion (n) | 379 ± 12 (50-890) | 179 ± 18 (50-460) | 0.03 |
12 | 5 | 0.04 |
- Citation: Yamazaki S, Takayama T. Surgical treatment of hepatocellular carcinoma: Evidence-based outcomes. World J Gastroenterol 2008; 14(5): 685-692
- URL: https://www.wjgnet.com/1007-9327/full/v14/i5/685.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.685